Skip to main content

full timeline

WADA Considers Adding Semaglutide to Prohibited List Ahead of LA28 Olympics

The World Anti-Doping Agency will continue to monitor but not ban medications like Ozempic and Mounjaro for the 2027 season, citing insufficient evidence of performance enhancement. The agency also narrowed its cannabinoid prohibition to focus specifically on THC-like compounds.

Factlen Newsroom· Updated

Follow WADA Considers Adding Semaglutide to Prohibited List Ahead of LA28 Olympics in the Factlen app and get an alert when there is news. Get the app

Endurance sports like cycling place a heavy premium on power-to-weight ratios, making weight-loss drugs a subject of intense regulatory scrutiny.From: WADA Keeps GLP-1 Weight-Loss Drugs Off 2027 Banned List, Updates Cannabinoid Rules

Share this story

Charts, maps and images

A 2026 Loughborough University survey revealed significant concern among sports medicine physicians regarding the off-label use of GLP-1 agonists.From: WADA Keeps GLP-1 Weight-Loss Drugs Off 2027 Banned List, Updates Cannabinoid Rules ·
While GLP-1 medications offer rapid weight loss, sports physicians warn of severe physiological trade-offs that can degrade athletic performance.From: WADA Considers Adding Semaglutide to Prohibited List Ahead of LA28 Olympics ·
WADA will continue to track the presence of GLP-1 agonists through its Monitoring Program while awaiting the results of two scientific studies.From: WADA Keeps GLP-1 Weight-Loss Drugs Off 2027 Banned List, Updates Cannabinoid Rules ·
Endurance sports like professional cycling are at the center of the debate over power-to-weight ratios and pharmaceutical interventions.From: WADA Considers Adding Semaglutide to Prohibited List Ahead of LA28 Olympics ·